Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil

BACKGROUND: Palivizumab prophylaxis for the human respiratory syncytial virus (HRSV) has been reported to reduce the risk of hospital admissions related to HRSV in children with congenital heart disease (CHD). These children are at high risk of developing severe lower respiratory tract infection (LR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Pediatr
Hauptverfasser: de Souza, Roseane Porfírio, Ribeiro, Andre Luis Ribeiro, de Menezes, Sílvio Augusto Fernandes, Machado, Luiz Fernando Almeida
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714430/
https://ncbi.nlm.nih.gov/pubmed/31462289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-019-1681-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge